Genome Compiler Corp. is building the next generation of computer-aided design tools for synthetic biology. In the age of Synthetic Biology, we need tools for designing, debugging and compiling genetic code; a genome compiler.
Founder and CEO
Omri Amirav-Drory, PhD, is the founder and CEO of Genome Compiler Corp., a synthetic biology venture. Prior to starting his company, Omri was a Fulbright postdoctoral research fellow at Stanford University School of Medicine and HHMI.